Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CRISPR Therapeutics AG | 19,357 | reported | 29 May 2026 | tx 19+362,132−38,993 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 22,000 | 0.00 USD | deriv |
| 28 May 2026 | EXERCISE | CRISPR Therapeutics AG | 10,000 | — | |
| 29 May 2026 | SALE | CRISPR Therapeutics AG | 3,786 | 55.62 USD | |
| 28 May 2026 | EXERCISE | CRISPR Therapeutics AG | 10,000 | — | deriv |
| 20 Mar 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 30,000 | 0.00 USD | deriv |
| 20 Mar 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 38,499 | 0.00 USD | deriv |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 8,125 | — | |
| 16 Mar 2026 | SALE | CRISPR Therapeutics AG | 3,150 | 48.26 USD | |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 8,125 | — | deriv |
| 03 Apr 2025 | PURCHASE | CRISPR Therapeutics AG | 1,508 | 32.96 USD | |
| 03 Oct 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 16,500 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 25,000 | 0.00 USD | deriv |
| 28 May 2025 | EXERCISE | CRISPR Therapeutics AG | 10,000 | — | |
| 29 May 2025 | SALE | CRISPR Therapeutics AG | 3,932 | 35.94 USD | |
| 28 May 2025 | EXERCISE | CRISPR Therapeutics AG | 10,000 | — | deriv |
| 14 Mar 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 46,667 | 0.00 USD | deriv |
| 14 Mar 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 32,500 | 0.00 USD | deriv |
| 16 Oct 2024 | GRANT_AWARD | CRISPR Therapeutics AG | 18,333 | 0.00 USD | deriv |
| 28 May 2024 | GRANT_AWARD | CRISPR Therapeutics AG | 40,000 | 0.00 USD | deriv |
| 28 May 2024 | GRANT_AWARD | CRISPR Therapeutics AG | 85,000 | 0.00 USD | deriv |